Health & Fitness
Wed, February 1, 2012
LOS ANGELES--([ BUSINESS WIRE ])--Please replace the release with the following corrected version due to multiple revisions.
The corrected release reads:
GLANCY BINKOW & GOLDBERG LLP ANNOUNCES INVESTIGATION OF ILLUMINA, INC.
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims against the Board of Directors of Illumina, Inc. (aIlluminaa or the aCompanya) (NASDAQ:ILMN) related to the receipt of a proposal from Roche to acquire the Company. The transaction is valued at approximately $5.7 billion or $44.50 per share.
The investigation concerns the board of directorsa process for consideration of the proposed transaction, and whether Illumina is acting in its shareholdersa best interests by refusing to enter into negotiations with Roche.
If you are a shareholder of Illumina, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Louis Boyarsky, Esquire, Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067, by telephone at (310) 201-9150 or Toll Free at (888) 773-9224 or by email to [ shareholders@glancylaw.com ].
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
